Fundraising FoxReservoir Neuroscience
San Francisco, US · Founded 2019 · 2 known investors
Find your way into Reservoir Neuroscience
Sign up to see every warm intro you have to Reservoir Neuroscience
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Reservoir Neuroscience team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Reservoir Neuroscience is developing therapeutics aimed at repairing the blood-brain barrier. The company operates in the neuroscience drug development space.
Founders & leadership
AF
Aaron FriedmanExecutive
VS
Vladimir SenatorovNamed on SEC filing
Board
TS
JS
James SummersBoard director
BS
Brian SlingerlandBoard director
Investors · 2
age1listed by age1San Francisco · $500K – $4M
How we know: age1's portfolio page · Not right? Tell us
Dolby Family Ventureslisted by Dolby Family VenturesSan Francisco
How we know: Dolby Family Ventures's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$9M disclosed across 3 rounds · 2021–2026
▶$3MraisedJun 2026 · 2 investors · BiotechnologyRule 506(b)
▶$3MraisedJun 2026 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Aaron FriedmanExecutive Officer
- James SummersDirector
- Vladimir SenatorovDirector
- Brian SlingerlandDirector
- Offering amount
- $8M
- Amount sold
- $3M
- First sale
- Jun 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.1MraisedNov 2023 · 7 investors · BiotechnologyRule 506(b)
▶$2.1MraisedNov 2023 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Brian SlingerlandDirector
- Vladimir SenatorovExecutive Officer, Director
- Aaron FriedmanExecutive Officer, Director
- Patrick BurgermeisterDirector
- James SummersDirector
- Offering amount
- $4.1M
- Amount sold
- $2.1M
- First sale
- Nov 2023
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$3.9MraisedAug 2021 · 16 investors · BiotechnologyRule 506(b)
▶$3.9MraisedAug 2021 · 16 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Aaron FriedmanExecutive Officer, Director
- Tracy SaxtonDirector
- Brian SlingerlandDirector
- Vladimir SenatorovExecutive Officer, Director
- Offering amount
- $8.8M
- Amount sold
- $3.9M
- First sale
- Aug 2021
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Reservoir Neuroscience do?
- Reservoir Neuroscience is developing therapeutics aimed at repairing the blood-brain barrier. The company operates in the neuroscience drug development space.
- Who are Reservoir Neuroscience's investors?
- Reservoir Neuroscience's investors include age1, Dolby Family Ventures.
- How much funding has Reservoir Neuroscience raised?
- Reservoir Neuroscience has disclosed $9M raised across 3 rounds.
- Where is Reservoir Neuroscience headquartered?
- Reservoir Neuroscience is headquartered in San Francisco, US.